-
May 20, 2024, 08:13 AM
by
Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).
Full story
-
May 20, 2024, 08:13 AM
by
Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.
Full story
-
May 17, 2024, 07:46 AM
by
https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime
Full story
-
May 17, 2024, 07:46 AM
by
Precision medicine biotechnology company for obesity secures additional institutional capital from prominent industry leaders to expand the use of its novel phenotyping test and advance clinical research in weight loss treatment.
Full story
-
May 17, 2024, 07:46 AM
by
Rob Sobie to support IntelliGuard’s ongoing innovation to track, trace, and improve safety in medication inventory
Full story
-
May 17, 2024, 07:46 AM
by
https://www.prnewswire.com/news-releases/mdclone-earns-fourth-consecutive-best-healthcare-big-data-platform-award-from-medtech-breakthrough-302147956.html?tc=eml_cleartime
Full story
-
May 17, 2024, 07:46 AM
by
Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes
Full story
-
May 17, 2024, 07:46 AM
by
Full story
-
May 16, 2024, 08:08 AM
by
Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards
Full story
-
May 16, 2024, 08:08 AM
by
Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.
Full story
-
May 16, 2024, 08:08 AM
by
IDT and Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their NGS capabilities.
Full story
-
May 16, 2024, 08:08 AM
by
Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.
Full story
-
May 16, 2024, 08:08 AM
by
Vector Laboratories joins forces with Absolute Biotech, bolstering its role as a key manufacturer for life science customers, enriching its antibody reagents portfolio, and expanding its commercial presence into the UK and EU.
Full story
-
May 16, 2024, 05:00 AM
by
User Not Found
Bio-IT World | The lab of W. Andy Tao, professor of biochemistry at Purdue University, is pioneering a way to assess drug response based on metabolizing proteins found in circulating extracellular vesicles (EVs), which could serve as a surrogate of their expression level in the liver and become therapeutic targets for some cancers.
Full story
-
May 15, 2024, 08:31 AM
by
Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.
Full story
-
May 15, 2024, 08:31 AM
by
Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.
Full story
-
May 15, 2024, 08:31 AM
by
Full story
-
May 15, 2024, 08:31 AM
by
Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.
Full story
-
May 15, 2024, 08:31 AM
by
Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer
Full story
-
May 15, 2024, 08:31 AM
by
InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs
Full story